Improvement of erythropoiesis in beta-thalassemic mice by continuous erythropoietin delivery from muscle

Keyphrases

• Erythropoietin 100%
• Erythropoiesis 100%
• Globin 100%
• Thalassemic Mice 100%
• β-Thalassemia (β-thal) 66%
• High Efficiency 33%
• Mouse Model 33%
• Therapeutic Approaches 33%
• Genetic Disease 33%
• Long-term Treatment 33%
• Adenovirus 33%
• Cell Proliferation 33%
• 1-year Follow-up 33%
• Anemia 33%
• Cell Membrane 33%
• Reticulocytes 33%
• Pathophysiologic 33%
• Cell Destruction 33%
• Mouse Skeletal muscle 33%
• Erythrocytes 33%
• Red Blood Cells 33%
• Continuous Delivery 33%
• Reduced Iron 33%
• Viral-mediated Gene Transfer 33%
• Disease Class 33%
• In Vivo Assay 33%
• Sustained Stimulation 33%
• Membrane Function 33%
• Erythrocyte Membrane 33%
• RhEPO 33%
• Ineffective Erythropoiesis 33%
• Hemolytic Anemia 33%
• Fetal Hemoglobin 33%
• Erythroid 33%
• Globin Chains 33%
• Erythroid Cells 33%
• Thalassemia Intermedia 33%
• Red Blood Cell Morphology 33%
• Thalassemic Patients 33%
• α-Globin Chain 33%
• Erythroid Precursors 33%
• Globin Chain Imbalance 33%

Biochemistry, Genetics and Molecular Biology

• Erythropoiesis 100%
• Embryonic Hemoglobin 100%
• Erythropoietin 100%
• Globin 100%
• Precursor 50%
• Globin Synthesis 50%
• Mouse Model 25%
• Fetal Hemoglobin 25%
• Genetic Disorder 25%
• Secretion (Process) 25%
• Cell Proliferation 25%
• Cell Membrane 25%
• Reticulocyte 25%
• Erythrocyte Membrane 25%
• Adeno Associated Virus 25%
• Cell Destruction 25%
• Darbepoetin Alfa 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Erythropoietin 100%
• Globin 100%
• Hemoglobin F 80%
• Beta Thalassemia 60%
• Mouse Model 20%
• Adeno Associated Virus 20%
• Disease 20%
• Genetic Disorder 20%
• Gene Delivery 20%
• Anemia 20%
• Recombinant Erythropoietin 20%
• Hemolytic Anemia 20%
• Hemoglobin Alpha Chain 20%
• Iron 59 20%
• Thalassemia Intermedia 20%